REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

10/03/2020 11:45

RNS Number : 5923F
  
Morgan Stanley Capital Services LLC
  
10 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   09 MARCH 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  24,047


 86.9500 USD


 82.9500 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  69,893


 86.9473 USD


 82.5900 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 216


 82.6786 USD




 CFD


 LONG


 433


 84.2592 USD




 CFD


 LONG


 625


 84.5273 USD




 CFD


 LONG


 875


 84.5273 USD




 CFD


 LONG


 1,698


 84.7187 USD




 CFD


 LONG


 257


 84.7187 USD




 CFD


 LONG


 3,397


 85.0524 USD




 CFD


 LONG


 15


 85.1208 USD




 CFD


 LONG


 207


 85.1208 USD




 CFD


 LONG


 9,200


 85.2700 USD




 CFD


 LONG


 31


 85.2700 USD




 CFD


 LONG


 800


 85.3068 USD




 CFD


 LONG


 500


 85.3068 USD




 CFD


 LONG


 5,500


 85.3068 USD




 CFD


 LONG


 50


 85.5000 USD




 CFD


 LONG


 16,924


 85.6762 USD




 CFD


 LONG


 396


 85.6762 USD




 CFD


 SHORT


 4,134


 83.1835 USD




 CFD


 SHORT


 78


 83.6300 USD




 CFD


 SHORT


 16


 84.9700 USD




 CFD


 SHORT


 200


 85.0000 USD




 CFD


 SHORT


 6


 85.2700 USD




 CFD


 SHORT


 17


 85.2700 USD




 CFD


 SHORT


 6,365


 85.3645 USD




 CFD


 SHORT


 1,900


 85.5371 USD




 CFD


 SHORT


 9,200


 85.5801 USD




 CFD


 SHORT


 175


 86.5244 USD




 CFD


 SHORT


 5


 86.5244 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 10 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEURORRRWUOAAR